Our Entrepreneurs

Christopher Whitfield

Batswadi Pharmaceuticals

Christopher Whitfield Christopher Whitfield
“I saw an opportunity to transform the pharmaceutical industry in South Africa.”
Country
South Africa
Industry
Healthcare
Year selected
2007
Website

Company Snapshot

Christopher founded Batswadi Pharmaceuticals in October 2005 as a specialist healthcare company focusing on four core business areas: pharmaceuticals, diagnostics, research and development, and consumer health. After jump-starting the company by leading a management buy-out of Eli Lilly’s insulin portfolio in South Africa, Christopher has quickly built Batswadi into a diversified company with significant potential. As the only black-empowered (majority-owned by historically disadvantaged South Africans) pharmaceutical company in South Africa, Batswadi is a rising star.

Endeavor and Batswadi Pharmaceuticals

Christopher is actively receiving guidance in the areas of fundraising and branding. In addition to local support, he has benefited from the Global eMBA and G-Lab programs, and an Immersion Tour.

Christopher has been on the Endeavor South Africa board since 2008, and serves as a local panelist.

From the Entrepreneurship Blog

Events

40 High-Impact Entrepreneurs from 13 Countries Join Network at the 56th International Selection Panel in Miami; Endeavor Peru Welcomes First Entrepreneurs

December 12th, 2014 — by admin

Miami, FL – December 11, 2014 – Endeavor selected 40 high-impact entrepreneurs leading 22 companies in 13 countries at its 56th International Selection Panel. Endeavor now supports 1,030 High-Impac…

Read more

In the news

Report on Scale-Up Entrepreneurship in the U.K. Examines Research from Endeavor

December 19th, 2014 — by admin

A new report titled The Scale-Up Report on UK Economic Growth has identified the impact of scale-up companies on the country's economy and highlighted the importance of supporting high-impact, high-…

Read more

Contact us

Press center

Community

Newsletter Sign Up